Technologies rarely advance at a steady and predictable pace, but new platforms and newer ideas are already shaping the future of clinical lab testing. This article from the April 2014 issue highlights a handful of companies that are working to bring new diagnostic technologies to market and improve patient care.
Read More
Although most popular hospital urine pregnancy tests perform well in the first month after conception, a new study finds that many become significantly more likely to produce false-negative results after the fifth to seventh week of pregnancy.
Read MoreAcquisition of IQuum’s unique products will enable Roche to quickly enter the point of care segment of molecular diagnostics.
Read More
Chembio Diagnostics has announced plans to build a US sales and marketing team after notifying Alere of the termination of its US Stat-Pak distribution agreement.
Read More
New products include a molecular diagnostic test from Alere and new line of high-performance liquid chromatography columns from Diamond Analytics.
Read More